Abstract
Acceleration of the drug discovery process in pre-clinical pharmaceutical research is a highly desirable goal and combinatorial chemistry united with automation technology promised to accomplish this task. Through the accumulation of experience with automated devices over time it became evident that only by harmonisation and streamlining of work-flow procedures the efficiency of the overall process can be improved. An open architecture of efficient data management and appropriate utilisation of automated laboratory protocols provides the opportunity to react in a flexible and advisable way. Only an integrative workflow concept promotes the enhancement of the overall performance. However, the foundation of any efforts towards the accelerated synthesis of new and desired compound arrays lies in the development of reliable chemistry protocols amenable to solid- and solution phase chemistry.
Keywords: drug discovery, combinatorial chemistry, parallel synthesis, laboratory automation, integrative workflow concept, case studies
Current Medicinal Chemistry
Title: Accelerating Drug Discovery by Integrative Implementation of Laboratory Automation in the Work Flow
Volume: 9 Issue: 23
Author(s): Matthias Nettekoven and Andrew W. Thomas
Affiliation:
Keywords: drug discovery, combinatorial chemistry, parallel synthesis, laboratory automation, integrative workflow concept, case studies
Abstract: Acceleration of the drug discovery process in pre-clinical pharmaceutical research is a highly desirable goal and combinatorial chemistry united with automation technology promised to accomplish this task. Through the accumulation of experience with automated devices over time it became evident that only by harmonisation and streamlining of work-flow procedures the efficiency of the overall process can be improved. An open architecture of efficient data management and appropriate utilisation of automated laboratory protocols provides the opportunity to react in a flexible and advisable way. Only an integrative workflow concept promotes the enhancement of the overall performance. However, the foundation of any efforts towards the accelerated synthesis of new and desired compound arrays lies in the development of reliable chemistry protocols amenable to solid- and solution phase chemistry.
Export Options
About this article
Cite this article as:
Nettekoven Matthias and Thomas W. Andrew, Accelerating Drug Discovery by Integrative Implementation of Laboratory Automation in the Work Flow, Current Medicinal Chemistry 2002; 9 (23) . https://dx.doi.org/10.2174/0929867023368764
DOI https://dx.doi.org/10.2174/0929867023368764 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Design and Synthesis of Aryl Hydroxamic Acid Inhibitors of MMPs and TACE
Current Topics in Medicinal Chemistry Bridging Indigenous Knowledge and Scientific Evidence for Pharmacological Studies of <i>Phaleria macrocarpa</i>: A Systematic Review
The Natural Products Journal Anti-Inflammatory Activity of Tetracyclines: Applications to Human Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Novel Asthma Therapies: A Review
Current Drug Therapy Magnitude and Clinical Profile of Juvenile Idiopathic Arthritis in a Medical College Hospital of a Socio-economically Disadvantaged Country
Current Rheumatology Reviews Editorial [Hot Topic:Supramolecular Devices for the High-Throughput Screening of Drugs,Nutrients and Metabolites in Postgenomic Era (Part 3) (Guest Editor: Grzegorz Bazylak)]
Combinatorial Chemistry & High Throughput Screening Fc Engineering to Improve the Function of Therapeutic Antibodies
Current Pharmaceutical Biotechnology The Role of TNF and Its Family Members in Inflammation and Cancer: Lessons from Gene Deletion
Current Drug Targets - Inflammation & Allergy Role of Glucocorticoids in Breast Cancer
Current Pharmaceutical Design Calcium Intake Requirements Along the Life Cycle and Associated Factors
Current Nutrition & Food Science Inhibitors and Breakers of Advanced Glycation Endproducts (AGEs): A Review
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Meet the Editorial Board Member
CNS & Neurological Disorders - Drug Targets Guggulsterone for Chemoprevention of Cancer
Current Pharmaceutical Design On the Paradigm Shift Towards Multitarget Selective Drug Design
Current Computer-Aided Drug Design Comparison of Large Proteomic Datasets
Current Proteomics Non Steroidal Anti-Inflammatory Drug Induced Damage on Lower Gastro-Intestinal Tract: Is There an Involvement of Microbiota?
Current Drug Safety Targeting Lipoxygenases (LOs): Drug Design And Discovery
Current Enzyme Inhibition Matrix Metalloproteinases as Valid Clinical Target
Current Pharmaceutical Design Molecular Mechanisms Involved in the Aging of the T-cell Immune Response
Current Genomics Obesity: The Metabolic Disease, Advances on Drug Discovery and Natural Product Research
Current Topics in Medicinal Chemistry